Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1203486A in metastatic cutaneous melanoma
NCT00706238Phase 2Terminated
- Sponsor
- GSK
- Start
- Sep 2008
- Primary completion
- Jan 2011
- Modality
- Vaccines & Immunotherapeutics, Peptides, Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 2 trial of astuprotimut-R in cutaneous melanoma (CM), sponsored by GSK. Started Sep 2008; status: terminated.
02
Drugs
astuprotimut-R
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on NCT00706238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00706238.